Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA, Olszewski AJ.
Curr Treat Options Oncol. 2018 Jun 21;19(8):38. doi: 10.1007/s11864-018-0555-8.
Primary large B-cell lymphomas of immune-privileged sites.
Roschewski M, Phelan JD, Jaffe ES.
Blood. 2024 Dec 19;144(25):2593-2603. doi: 10.1182/blood.2023020911.
How we treat primary central nervous system lymphoma.
Calimeri T, Steffanoni S, Gagliardi F, Chiara A, Ferreri AJM.
ESMO Open. 2021 Aug;6(4):100213. doi: 10.1016/j.esmoop.2021.100213. Epub 2021 Jul 13.
CAR T-cell therapy in large B cell lymphoma.
Boardman AP, Salles G.
Hematol Oncol. 2023 Jun;41 Suppl 1(Suppl 1):112-118. doi: 10.1002/hon.3153.
Ibrutinib in primary central nervous system diffuse large B-cell lymphoma.
T Low J, B Peters K.
CNS Oncol. 2020 Mar 1;9(1):CNS51. doi: 10.2217/cns-2019-0022. Epub 2020 Mar 6.
The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke J, Ishaque N, Koll R, Gu Z, Schumann E, Sieverling L, Uhrig S, Hübschmann D, Toprak UH, López C, Hostench XP, Borgoni S, Juraeva D, Pritsch F, Paramasivam N, Balasubramanian GP, Schlesner M, Sahay S, Weniger M, Pehl D, Radbruch H, Osterloh A, Korfel A, Misch M, Onken J, Faust K, Vajkoczy P, Moskopp D, Wang Y, Jödicke A, Trümper L, Anagnostopoulos I, Lenze D, Küppers R, Hummel M, Schmitt CA, Wiestler OD, Wolf S, Unterberg A, Eils R, Herold-Mende C, Brors B; ICGC MMML-Seq Consortium; Siebert R, Wiemann S, Heppner FL.
Nat Commun. 2022 May 10;13(1):2558. doi: 10.1038/s41467-022-30050-y.
Molecular and clinical diversity in primary central nervous system lymphoma.
Hernández-Verdin I, Kirasic E, Wienand K, Mokhtari K, Eimer S, Loiseau H, Rousseau A, Paillassa J, Ahle G, Lerintiu F, Uro-Coste E, Oberic L, Figarella-Branger D, Chinot O, Gauchotte G, Taillandier L, Marolleau JP, Polivka M, Adam C, Ursu R, Schmitt A, Barillot N, Nichelli L, Lozano-Sánchez F, Ibañez-Juliá MJ, Peyre M, Mathon B, Abada Y, Charlotte F, Davi F, Stewart C, de Reyniès A, Choquet S, Soussain C, Houillier C, Chapuy B, Hoang-Xuan K, Alentorn A.
Ann Oncol. 2023 Feb;34(2):186-199. doi: 10.1016/j.annonc.2022.11.002. Epub 2022 Nov 17.
Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers.
Loser V, Segot A, de Leval L, Bisig B, Brouland JP, Hewer E, Barcena C, Hottinger AF, Pot C.
BMC Neurol. 2024 Jul 22;24(1):250. doi: 10.1186/s12883-024-03761-6.
Primary testicular lymphoma.
Grainger BT, Cheah CY.
Cancer Treat Rev. 2025 May;136:102927. doi: 10.1016/j.ctrv.2025.102927. Epub 2025 Apr 10.
Real-world analysis of primary central nervous system diffuse large B-cell lymphoma.
Wang H, Li J, Cao L, Zhang Y, Wan X, Wang X, Li Z, Wang B, Bai O.
Crit Rev Oncol Hematol. 2025 Nov;215:104928. doi: 10.1016/j.critrevonc.2025.104928. Epub 2025 Sep 9.
